Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC, Oudshoorn SC, Eijkemans MJC, Mochtar MH, van Golde RJT, Hoek A, Kuchenbecker WKH, Fleischer K, de Bruin JP, Groen H, van Wely M, Lambalk CB, Laven JSE, Mol BWJ, Broekmans FJM, Torrance HL; OPTIMIST study group. van Tilborg TC, et al. Among authors: oudshoorn sc. Hum Reprod. 2017 Dec 1;32(12):2485-2495. doi: 10.1093/humrep/dex321. Hum Reprod. 2017. PMID: 29121350 Clinical Trial.
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
Oudshoorn SC, van Tilborg TC, Eijkemans MJC, Oosterhuis GJE, Friederich J, van Hooff MHA, van Santbrink EJP, Brinkhuis EA, Smeenk JMJ, Kwee J, de Koning CH, Groen H, Lambalk CB, Mol BWJ, Broekmans FJM, Torrance HL; OPTIMIST study group. Oudshoorn SC, et al. Hum Reprod. 2017 Dec 1;32(12):2506-2514. doi: 10.1093/humrep/dex319. Hum Reprod. 2017. PMID: 29121269 Clinical Trial.
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, Nap AW, Scheffer GJ, Manger AP, Schoot BC, Sluijmer AV, Verhoeff A, Groen H, Laven JSE, Mol BWJ, Broekmans FJM; OPTIMIST study group. van Tilborg TC, et al. Among authors: oudshoorn sc. Hum Reprod. 2017 Dec 1;32(12):2496-2505. doi: 10.1093/humrep/dex318. Hum Reprod. 2017. PMID: 29121326 Clinical Trial.
Cumulative live birth rates in low-prognosis women.
Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, van Golde RJT, Hoek A, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Torrance HL, Broekmans FJM; OPTIMIST study group. Leijdekkers JA, et al. Among authors: oudshoorn sc. Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051. Hum Reprod. 2019. PMID: 31125412 Free PMC article.
Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial.
Leijdekkers JA, van Tilborg TC, Torrance HL, Oudshoorn SC, Brinkhuis EA, Koks CAM, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Broekmans FJM, Eijkemans MJC; OPTIMIST study group. Leijdekkers JA, et al. Among authors: oudshoorn sc. Acta Obstet Gynecol Scand. 2019 Oct;98(10):1332-1340. doi: 10.1111/aogs.13664. Epub 2019 Jun 21. Acta Obstet Gynecol Scand. 2019. PMID: 31127607 Free article. Clinical Trial.
Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.
Schouten N, Wang R, Torrance H, Van Tilborg T, Bastu E, Bergh C, D'Hooghe T, Friis Petersen J, Jayaprakasan K, Khalaf Y, Klinkert E, La Marca A, Vuong L, Lapensée L, Lensen S, Magnusson Å, Allegra A, Nyboe Andersen A, Oudshoorn S, Popovic-Todorovic B, Mol BW, Eijkemans M, Broekmans F. Schouten N, et al. Hum Reprod Update. 2024 Dec 20:dmae032. doi: 10.1093/humupd/dmae032. Online ahead of print. Hum Reprod Update. 2024. PMID: 39707165
11 results